These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1510 related items for PubMed ID: 19948300

  • 61. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.
    Am Heart J; 2010 Feb; 159(2):238-44. PubMed ID: 20152222
    [Abstract] [Full Text] [Related]

  • 62. Heart failure: clinical problem and management issues.
    Nicklas JM, Bleske BE, Van Harrison R, Hogikyan RV, Kwok Y, Chavey WE.
    Prim Care; 2013 Mar; 40(1):17-42. PubMed ID: 23402460
    [Abstract] [Full Text] [Related]

  • 63. Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new.
    Talameh JA, McLeod HL, Adams KF, Patterson JH.
    J Card Fail; 2012 Apr; 18(4):338-49. PubMed ID: 22464776
    [Abstract] [Full Text] [Related]

  • 64. Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).
    Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.
    Am J Cardiol; 2010 Jun 15; 105(12):1773-9. PubMed ID: 20538129
    [Abstract] [Full Text] [Related]

  • 65. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
    Maeder MT, Rickli H, Pfisterer ME, Muzzarelli S, Ammann P, Fehr T, Hack D, Weilenmann D, Dieterle T, Kiencke S, Estlinbaum W, Brunner-La Rocca HP, TIME-CHF Investigators.
    Am Heart J; 2012 Mar 15; 163(3):407-14, 414.e1. PubMed ID: 22424011
    [Abstract] [Full Text] [Related]

  • 66. Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.
    Chen JY, Kang N, Juarez DT, Yermilov I, Braithwaite RS, Hodges KA, Legorreta A, Chung RS.
    J Healthc Qual; 2011 Mar 15; 33(4):29-36. PubMed ID: 21733022
    [Abstract] [Full Text] [Related]

  • 67. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.
    Gheorghiade M, Albert NM, Curtis AB, Thomas Heywood J, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC.
    Congest Heart Fail; 2012 Mar 15; 18(1):9-17. PubMed ID: 22277172
    [Abstract] [Full Text] [Related]

  • 68. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
    O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Piña I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorghiade M, Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators.
    Am Heart J; 2010 May 15; 159(5):841-849.e1. PubMed ID: 20435194
    [Abstract] [Full Text] [Related]

  • 69. Ivabradine: beyond heart rate control.
    Riccioni G, Vitulano N, D'Orazio N.
    Adv Ther; 2009 Jan 15; 26(1):12-24. PubMed ID: 19165437
    [Abstract] [Full Text] [Related]

  • 70. Treating hypertension in the very elderly.
    Charpentier MM, Bundeff A.
    Ann Pharmacother; 2011 Sep 15; 45(9):1138-43. PubMed ID: 21852597
    [Abstract] [Full Text] [Related]

  • 71. Risk-treatment mismatch in the pharmacotherapy of heart failure.
    Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A.
    JAMA; 2005 Sep 14; 294(10):1240-7. PubMed ID: 16160132
    [Abstract] [Full Text] [Related]

  • 72. Secondary prevention of stroke in the elderly: a review of the evidence.
    Alhusban A, Fagan SC.
    Am J Geriatr Pharmacother; 2011 Jun 14; 9(3):143-52. PubMed ID: 21570361
    [Abstract] [Full Text] [Related]

  • 73. Characteristics and outcomes of very elderly patients after first hospitalization for heart failure.
    Shah RU, Tsai V, Klein L, Heidenreich PA.
    Circ Heart Fail; 2011 May 14; 4(3):301-7. PubMed ID: 21467294
    [Abstract] [Full Text] [Related]

  • 74. Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: a propensity-adjusted case-control populational study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Almenara J, Gomez F.
    Int J Cardiol; 2011 Jan 07; 146(1):51-5. PubMed ID: 19573938
    [Abstract] [Full Text] [Related]

  • 75. Phosphodiesterase type 5 inhibitors as adjunctive therapy in the management of systolic heart failure.
    Cvelich RG, Roberts SC, Brown JN.
    Ann Pharmacother; 2011 Dec 07; 45(12):1551-8. PubMed ID: 22116990
    [Abstract] [Full Text] [Related]

  • 76. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups.
    Mogensen UM, Ersbøll M, Andersen M, Andersson C, Hassager C, Torp-Pedersen C, Gustafsson F, Køber L.
    Eur J Heart Fail; 2011 Nov 07; 13(11):1216-23. PubMed ID: 21896536
    [Abstract] [Full Text] [Related]

  • 77. Treatment of heart failure with preserved ejection fraction.
    Barnes MM, Dorsch MP, Hummel SL, Koelling TM, Bleske BE.
    Pharmacotherapy; 2011 Mar 07; 31(3):312-31. PubMed ID: 21361741
    [Abstract] [Full Text] [Related]

  • 78. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines.
    Bozkurt B.
    Curr Cardiol Rep; 2018 Apr 17; 20(6):39. PubMed ID: 29667019
    [Abstract] [Full Text] [Related]

  • 79. Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Zaragoza-Macias E, Zaidi AN, Dendukuri N, Marelli A.
    Circulation; 2019 Apr 02; 139(14):e801-e813. PubMed ID: 30586770
    [Abstract] [Full Text] [Related]

  • 80. [Diagnosis and treatment of anemia in heart failure patients].
    Santilli G, Tarantini L, Baio P, Senni M.
    G Ital Cardiol (Rome); 2011 May 02; 12(5):319-26. PubMed ID: 21593950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 76.